“…Although cases with delayed replacement surgery showed no signs of malignancy or contralateral involvement (26), these patients showed negligible results on conservative treatment. Although Low-dose aspirin and monoclonal antibody against human receptor activator of nuclear factor-κ B ligand (RANKL) were benefit for maintaining bone mass and qualities by activation of osteoblastic bone formation and inhibition of osteoclast activities via cyclooxygenase-independent manner (37,38), the use of drugs such as NSAIDs, alendronate sodium hydrate and alfacalcidol had only mild or even no effect on the patients with RDA (3,5,6,20,24,39,40). Total hip replacement is probably the treatment of choice for these patients.…”